[{"AccountsPayableCurrent_0_Q1_USD":11277000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":2091000.0,"TaxesPayableCurrent_0_Q1_USD":284000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":-25000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-69756000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":1178770000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":758000.0,"StockIssuedDuringPeriodValueTreasuryStockReissued_1_Q1_USD":889000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":887458.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q1_USD":25.25,"OtherNonoperatingIncome_1_Q1_USD":4232000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q1_shares":3697079.0,"NonoperatingIncomeExpense_1_Q1_USD":4232000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q1_USD":107300000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":1340000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":45.73,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":19.37,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":32.82,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":8495315.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1_Q1_USD":42.2,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1_Q1_shares":86114.0,"OtherAssetsNoncurrent_0_Q1_USD":662000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":221000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":1132000.0,"TreasuryStockValue_0_Q1_USD":63000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":40321000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":42390000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":9005000.0,"NumberOfOperatingSegments_1_Q1_Segment":1.0,"FairValueNetAssetLiability_0_Q1_USD":16000000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_1_Q1_USD":-25000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":11776000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":803000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-54059000.0,"TreasuryStockShares_0_Q1_shares":232396.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":894753000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":14151000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":11951000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q1_USD":32.82,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q1_shares":8495315.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":5431000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":14151000.0,"OtherLiabilitiesCurrent_0_Q1_USD":11793000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":-25000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-157000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q1_USD":6784000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":1694000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":45896000.0,"OtherNoncashExpense_1_Q1_USD":890000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":1132000.0,"LiabilitiesCurrent_0_Q1_USD":55086000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":1007300000.0,"Liabilities_0_Q1_USD":121203000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-29659000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":25018000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":377000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-69354000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":19550000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-2991000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-1.15,"CommonStockValue_0_Q1_USD":1850000.0,"CommonStockSharesOutstanding_0_Q1_shares":60890035.0,"CommonStockSharesIssued_0_Q1_shares":61122431.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":889712000.0,"AssetsCurrent_0_Q1_USD":929282000.0,"Assets_0_Q1_USD":1007300000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":9462375.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-18000.0,"AccountsReceivableNetCurrent_0_Q1_USD":25117000.0,"Depreciation_1_Q1_USD":2100000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-52175000.0,"NetIncomeLoss_1_Q1_USD":-69731000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":2991000.0,"IncreaseDecreaseInOtherOperatingLiabilities_1_Q1_USD":-1601000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-2496000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":-0.005,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":14123000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":1388000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":88466.0,"ShareBasedCompensation_1_Q1_USD":14151000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":54193000.0,"OperatingIncomeLoss_1_Q1_USD":-73586000.0,"OperatingExpenses_1_Q1_USD":73743000.0,"CommonStockSharesAuthorized_0_Q1_shares":103901006.0,"CommonStockParOrStatedValuePerShare_0_Q1_CHF":0.03,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":21924000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":60847683.0,"StockholdersEquity_0_Q1_USD":886097000.0,"Revenues_1_Q1_USD":157000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-294442000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":31773000.0,"ProfitLoss_1_Q1_USD":-69731000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":14453000.0,"PropertyPlantAndEquipmentFairValueDisclosure_0_Q1_USD":9340000.0,"RestrictedCashNoncurrent_0_Q1_USD":5041000.0,"Ticker":"CRSP","CIK":"1674416","name":"CRISPR THERAPEUTICS AG","OfficialName":"CRISPR Therapeutics AG Common Shares","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4543904930.0","Country":"Switzerland","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200428"}]